Bilgin Cömert

510 total citations
46 papers, 329 citations indexed

About

Bilgin Cömert is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Nutrition and Dietetics. According to data from OpenAlex, Bilgin Cömert has authored 46 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Pulmonary and Respiratory Medicine and 7 papers in Nutrition and Dietetics. Recurrent topics in Bilgin Cömert's work include Sepsis Diagnosis and Treatment (8 papers), Respiratory Support and Mechanisms (7 papers) and COVID-19 Clinical Research Studies (4 papers). Bilgin Cömert is often cited by papers focused on Sepsis Diagnosis and Treatment (8 papers), Respiratory Support and Mechanisms (7 papers) and COVID-19 Clinical Research Studies (4 papers). Bilgin Cömert collaborates with scholars based in Türkiye, United States and Serbia. Bilgin Cömert's co-authors include Orhan Çınar, Levent Yamanel, Begüm Ergan, Erdem Çevik, Mehmet Refik Mas, Ahmet Uzun, Ali Osman Yıldırım, A Dinç, Mehmet Yaşar and Murat Emre Tokur and has published in prestigious journals such as SHILAP Revista de lepidopterología, Critical Care and Alzheimer s & Dementia.

In The Last Decade

Bilgin Cömert

38 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bilgin Cömert Türkiye 11 98 97 69 46 45 46 329
Venkat Shankar United States 11 85 0.9× 85 0.9× 53 0.8× 49 1.1× 62 1.4× 22 464
Wanhong Yin China 11 94 1.0× 73 0.8× 42 0.6× 60 1.3× 26 0.6× 60 340
Petch Wacharasint Thailand 8 132 1.3× 188 1.9× 59 0.9× 25 0.5× 39 0.9× 27 416
Bret D. Alvis United States 12 186 1.9× 99 1.0× 164 2.4× 34 0.7× 43 1.0× 34 491
Erdem Çevik Türkiye 8 64 0.7× 44 0.5× 62 0.9× 70 1.5× 29 0.6× 34 314
Daniel Dankl Austria 10 92 0.9× 89 0.9× 39 0.6× 45 1.0× 57 1.3× 19 286
Nanhi Mitter United States 7 125 1.3× 84 0.9× 127 1.8× 18 0.4× 67 1.5× 8 398
Megan L. Krajewski United States 7 80 0.8× 57 0.6× 66 1.0× 32 0.7× 46 1.0× 14 375
George Ε. Zakynthinos Greece 11 64 0.7× 62 0.6× 98 1.4× 40 0.9× 38 0.8× 57 394
Thomas Auchet France 5 148 1.5× 150 1.5× 86 1.2× 10 0.2× 122 2.7× 6 384

Countries citing papers authored by Bilgin Cömert

Since Specialization
Citations

This map shows the geographic impact of Bilgin Cömert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilgin Cömert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilgin Cömert more than expected).

Fields of papers citing papers by Bilgin Cömert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bilgin Cömert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilgin Cömert. The network helps show where Bilgin Cömert may publish in the future.

Co-authorship network of co-authors of Bilgin Cömert

This figure shows the co-authorship network connecting the top 25 collaborators of Bilgin Cömert. A scholar is included among the top collaborators of Bilgin Cömert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bilgin Cömert. Bilgin Cömert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurtkulağı, Özge, et al.. (2025). ICU admission delays: Impact on length of stay and long-term outcomes. Biomolecules and Biomedicine. 26(3). 499–508.
2.
Heybeli, Cihan, et al.. (2023). Dexmedetomidine may reduce the risk of acute kidney injury development in critically ill patients during colistin therapy. Journal of Infection and Chemotherapy. 29(7). 673–677. 3 indexed citations
3.
Altıntaş, Neriman Defne, Burçin Halaçlı, Melda Türkoğlu, et al.. (2023). Nutritional practices in medical intensive care units: Multicenter, one-day point prevalence study. Nutrition Clinique et Métabolisme. 37(4). 221–226.
4.
Cömert, Bilgin, et al.. (2022). Risk Factors of 90-Day Mortality in Patients with Critical Covid-19 Infection. Çanakkale Onsekiz Mart University AVESIS. 1 indexed citations
5.
Ergan, Begüm, et al.. (2022). Usefulness of Bispectral Index Monitoring for the Detection and Diagnosis of the Brain Death. SHILAP Revista de lepidopterología. 21(1). 1–7. 1 indexed citations
6.
Heybeli, Cihan, et al.. (2022). Amikacin-induced acute kidney injury in mechanically ventilated critically ill patients with sepsis. Journal of Chemotherapy. 35(6). 496–504. 4 indexed citations
7.
Yaka, Erdem, et al.. (2022). The effect of frailty on the development of acute kidney injury in critically-ill geriatric patients with COVID-19. TURKISH JOURNAL OF MEDICAL SCIENCES. 52(5). 1495–1503. 2 indexed citations
8.
Gökmen, Necati, et al.. (2021). Potentially inappropriate medication use in elderly patients treated in intensive care units: A cross‐sectional study using 2019 Beers, STOPP/v2 Criteria and EU(7)‐PIM List. International Journal of Clinical Practice. 75(11). e14802–e14802. 4 indexed citations
9.
Ergan, Begüm, et al.. (2021). New‐onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID‐19). Journal of Arrhythmia. 37(5). 1196–1204. 19 indexed citations
10.
Ergan, Begüm, et al.. (2021). Clinical characteristics and risk factors for 28-day mortality in critically ill patients with COVID-19: a retrospective cohort study. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(5). 2285–2295. 4 indexed citations
11.
Cömert, Bilgin, et al.. (2021). A rare presentation of panitumumab-involved interstitial lung disease: Spontaneous pneumomediastinum. Journal of Oncology Pharmacy Practice. 27(8). 2061–2065.
13.
Ergan, Begüm, et al.. (2019). Current Status of Organ Donation in a University Hospital in İzmir: Identifying Obstacles and Possible Future Solutions. SHILAP Revista de lepidopterología. 17(3). 154–160. 3 indexed citations
14.
Tokur, Murat Emre, Begüm Ergan, Erdem Yaka, et al.. (2019). Depression and Burnout Frequency in Nurses Working in Tertiary Intensive Care Units. 9(2). 25–33. 7 indexed citations
15.
Tokur, Murat Emre, et al.. (2016). Hasta Yakınlarında Yoğun Bakım Algısı ve Memnuniyeti. 7(2). 57–61. 1 indexed citations
17.
İnal, Volkan, Levent Yamanel, Gürhan Taşkın, Serkan Tapan, & Bilgin Cömert. (2015). Paraoxonase 1 Activity and Survival in Sepsis Patients. Balkan Medical Journal. 32(2). 183–188. 13 indexed citations
18.
Çınar, Orhan, et al.. (2012). A Randomized Clinical Trial Comparing the Effect of Rapidly Infused Crystalloids on Acid-Base Status in Dehydrated Patients in the Emergency Department. International Journal of Medical Sciences. 9(1). 59–64. 36 indexed citations
19.
Eroğlu, Murat, Orhan Çınar, Erdem Çevik, et al.. (2011). The Analysis of Cases Admitted to Intensive Care Units from Emergency Department Due to Complications Related to Warfarin Treatment. Turkish Journal of Emergency Medicine. 11(1). 9–12. 1 indexed citations
20.
Cömert, Bilgin, et al.. (2001). Insulin resistance in non-alcoholic steatohepatitis. Digestive and Liver Disease. 33(4). 353–358. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026